Loading clinical trials...
Loading clinical trials...
A Phase 2a, Multi-center, Placebo-Controlled, Randomized, Assessor-blind Study to Assess the Safety & Efficacy of Parenteral TK-90 or Parenteral TK-90 Placebo to Patients Receiving Radiotherapy for Non-Metastatic Squamous Cell Carcinoma of Head and Neck.
Conditions
Interventions
TK-112690
Placebo
Locations
5
India
Sher-I-Kashmir Institute of Medical Sciences
Srinagar, Jammu and Kashmir, India
Bangalore Medical college and Research Institute
Bangalore, Karnataka, India
Saveetha Medical College and Hospita
Chennai, Tamil Nadu, India
Apex Hospital
Varanasi, Uttar Pradesh, India
Netaji Subhash Chandra Bose Hospital
Kolkata, West Bengal, India
Start Date
June 17, 2022
Primary Completion Date
September 1, 2023
Completion Date
September 1, 2023
Last Updated
August 14, 2023
NCT05853692
NCT06305000
NCT03983369
NCT07040969
NCT07047261
NCT06968520
Lead Sponsor
Tosk, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions